Who is Dr Ania and her medical background?

1. Who is Dr. Ania Jastreboff — the obesity specialist in national coverage

Ania M. Jastreboff, MD, PhD, is described by Yale Medicine as an adult and pediatric endocrinologist with expertise in obesity medicine and weight management; she cares for patients with prediabetes, insulin resistance, metabolic syndrome, and type 1 and type 2 diabetes, and she is director of the Yale Obesity Research Center (Y‑Weight) ^[1]. Mass‑market reporting about Oprah’s book and her podcast appearances identifies Dr. Ania Jastreboff as an endocrinologist at Yale who discussed modern weight‑loss science and GLP‑1 medications ^{[2] [3]}.

2. Academic and clinical footprint cited in available profiles

Yale’s specialist profile lists Jastreboff’s role, clinical focus, and recent publications tied to obesity treatment research — including letters or trial papers on agents such as tirzepatide and maridebart cafraglutide published in high‑impact journals in 2025 (New England Journal of Medicine and JAMA listings are cited on her Yale page) — signaling active involvement in obesity pharmacotherapy research ^[1]. Oprah’s podcast appearance with Jastreboff framed her publicly as an expert explaining GLP‑1 medications including Ozempic, Wegovy, Mounjaro, and Zepbound ^[3].

3. Multiple “Dr. Ania” identities in directories — do not assume a single person

Public directories and provider listings show several clinicians with the given name Ania but different surnames and specialties: Ania Janicka, DO, a diabetes & metabolism endocrinologist based in Florida with training and fellowship info in endocrinology and metabolic disorders ^{[4] [5] [8]}; Ania Aniol, MD, a psychiatrist with medical training from Poznan University and a psychiatry residency ^{[9] [6]}; Ania Busza, MD, PhD, whose profile notes MIT undergraduate degrees and MD/PhD training at UMass ^[7]. These are distinct practitioners and not the Yale endocrinologist identified in national coverage ^{[1] [4] [7] [6]}.

4. What the sources confirm and what they don’t

Sources confirm Jastreboff’s Yale affiliation, specialty in adult and pediatric endocrinology, leadership at Yale’s obesity center, public media appearances with Oprah, and citations of 2025 research items on obesity pharmacotherapy ^{[1] [2] [3]}. Available sources do not mention her specific medical school, residency locations, or full CV details beyond the Yale profile and cited publications; they also do not claim that other “Dr. Ania” entries in directories are the same person ^{[1] [4] [7]}.

5. How coverage frames her role on weight‑loss medications and public debates

Mainstream outlets and podcasts present Dr. Ania Jastreboff as an expert explaining the science behind GLP‑1 therapies and arguing against stigma that treats obesity as a moral failure rather than a medical condition — a framing used in articles about Oprah’s book and in related TV/podcast programming ^{[2] [3]}. Her Yale profile’s citations of trial publications indicate she is engaged in clinical and research conversations about new obesity medications ^[1].

6. Caveats, possible confusion, and how to verify further

Because “Ania” is a relatively common given name and public databases list multiple clinicians with that first name, readers should verify identity by surname and affiliation before attributing statements or credentials; Yale Medicine’s specialist page is the clearest source for Ania M. Jastreboff’s role ^[1]. For other clinicians named Ania, consult the specific directory or institutional profile (e.g., Medical News Today, Doximity, URMC) for specialty and training details ^{[4] [5] [7]}.

If you want, I can pull together a concise one‑page CV for Ania M. Jastreboff from the Yale profile plus the cited publications, or search these same sources for specific training details (medical school, residency) for each “Dr. Ania” listed.